Cell-mediated oxidation of LDL: Comparison of different cell types of the atherosclerotic lesion

Free Radical Research

Volumn 29, Issue 3, 1998, Pages 207-220

  Muller K ^a   Carpenter, K L H ^a   Mitchinson, M J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis; Cytotoxicity; Endothelial cells; LDL oxidation; Macrophages; Smooth muscle cells

Indexed keywords

7BETA HYDROXYCHOLESTEROL; ARACHIDONIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; POLYUNSATURATED FATTY ACID; STEARIC ACID;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPID OXIDATION; MACROPHAGE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

AORTA; ARACHIDONIC ACID; ARTERIOSCLEROSIS; CELLS, CULTURED; CHOLESTEROL; CHROMATOGRAPHY, GAS; CULTURE MEDIA; ELECTROPHORESIS, AGAR GEL; ENDOTHELIUM, VASCULAR; HUMANS; LINOLEIC ACID; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; OLEIC ACID; OXIDATION-REDUCTION; STEARIC ACIDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0031740587     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715769800300241     Document Type: Article

References (57)

1. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo and J.L. Witztum (1989) Beyond cholesterol; modifications of low density lipoprotein that increase its atherogeniciry. New England Journal of Medicine, 320, 915-924.
2. R. Ross (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801-809.
3. S. Ylä-Herttuala, W. Palinski, M.E. Rosenfeld, S. Parthasarathy, T.E. Carew, S. Butler, J.L. Witztum and D. Steinberg (1989) Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigation, 84, 1086-1095.
4. D.V. Parums, D.L. Brown and M.J. Mitchinson (1990) Serum antibodies to oxidised low density lipoprotein and ceroid in chronic periaortitis. Archives of Pathology and Laboratory Medicine, 114, 383-387.
5. M.T. Quinn, S. Parthasarathy, L.G. Fong and D. Steinberg (1987) Oxidatively-modified LDL's: a potential role in recruitment and retention of monocyte-macrophages during atherogenesis. Proceedings of the National Academy of Sciences of the USA, 84, 2995-2888.
6. M.S. Brown and J.L. Goldstein (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annual Review of Biochemistry, 52, 223-261.
7. G. Endemann, L.W. Stanton, K.S. Madden, C.M. Bryant, R.T. White and A.A. Protter (1993) CD36 is a receptor for oxidised low density lipoprotein. Journal of Biological Chemistry, 268, 11811-11816.
8. S. Parthasarathy, D.J. Printz, D. Boyd, L. Joy and D. Steinberg (1986) Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis, 6, 505-510.
9. R. Y. Ball, J.P. Bindman, K.L.H. Carpenter and M.J. Mitchinson (1986) Oxidised low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro. Atherosclerosis, 60, 173-181.
10. R.Y. Ball, K.L.H. Carpenter and M.J. Mitchinson (1987) What is the significance of ceroid in human atherosclerosis? Archives of Pathology and Laboratory Medicine, 111, 1134-1140.
11. M.J. Mitchinson (1982) Insoluble lipids in human atherosclerotic plaques. Atherosclerosis, 45, 11-15.
12. M.J. Mitchinson, D.C. Hothersall and P.N. Brooks (1985) The distribution of ceroid in human atherosclerosis. Journal of Pathology, 145, 177-183.
13. C.E. Marchant, N.S. Law, C. van der Veen, S.J. Hardwick, K.L.H. Carpenter and M.J. Mitchinson (1995) Oxidized low-density lipoprotein is cytotoxic to human monocytemacrophages: protection with lipophilic antioxidants. FEBS Letters, 358, 175-178.
14. [14[ C.E. Marchant, C. van der Veen, N.S. Law, S.J. Hardwick, K.L.H. Carpenter and M.J. Mitchinson (1996) Oxidation of low-density lipoprotein by human monocyte-macrophages results in toxicity to the oxidising culture. Free Radical Research, 24, 333-342.
15. H. Hughes, B. Matthews, M.L. Lenz and J.R. Guyton (1994) Cytotoxicity of oxidised LDL to porcine aortic smooth muscle cells is associated with the oxysterol 7-ketocholesterol and 7-hydroxycholesterol. Arteriosclerosis and Thrombosis, 14, 1177-1185.
16. R.Y. Ball, E.C. Stowers, J.H. Burton, N.R.B. Cary, J.N. Skepper and M.J. Mitchinson (1995) Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis, 114, 45-54.
17. J.H. Braesen, U. Beisiegel and A. Niendorf (1995) Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits. Virchow's Archives, 426, 179-188.
18. N.G. Stephens, A. Parsons, P.M. Schofield, F. Kelly, K. Cheeseman, M.J. Mitchinson and M.J. Brown (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). The Lancet, 347, 781-786.
19. D.S. Leake and S.M. Rankin (1990) The oxidative modification of low density lipoproteins by macrophages. Biochemical Journal, 270, 741-748.
20. K.L.H. Carpenter, G.M. Fussell, J.A. Ballantine, S.E. Taylor, M.J. Mitchinson and D.S. Leake (1994) Production of oxidised lipids during modification of low density lipoprotein by macrophages or copper. Biochemical Journal, 304, 625-633.
21. J.W. Heinecke, H. Rosen and A. Chait (1984) Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. Journal of Clinical Investigation, 74, 1890-1894.
22. J. Morgan, J.A. Smith, G.M. Wilkins and D.S. Leake (1993) Oxidation of low density lipoprotein by bovine and porcine aortic endothelial cells and porcine endocardial cells in culture. Atherosclerosis, 102, 209-216.
23. D.J. Lamb, G.M. Wilkins and D.S. Leake (1992) The oxidative modification of low density lipoprotein by human lymphocytes. Atherosclerosis, 92, 187-192.
24. C. Smith, M.J. Mitchinson, O.I. Aruoma and B. Halliwell (1992) Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochemical Journal, 286, 901-905.
25. J. Swain and M.C. Gutteridge (1995) Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Letters, 368, 513-515.
26. D.J. Lamb, M.J. Mitchinson and D.S. Leake (1995) Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Letters, 374, 12-16.
27. R.J. Havel, H.A. Eder and J.H. Bragdon (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation, 34, 1345-1353.
28. O.H. Lowry, N.J. Rosebrough, A.L. Farr and R.J. Randall (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
29. W.D. Johnson, B. Mei and Z.A. Cohn (1977) The separation, long-term cultivation, and maturation of the human monocyte. Journal of Experimental Medicine, 146, 1613-1626.
30. E.H. Helsinki, K.L. Bielat, G.M. Ovak and J.L. Pauly (1988) Long-term cultivation of functional human macrophages in teflon dishes with serum free media. Journal of leukocyte Biology, 44, 111-121.
31. E.M. Denholm and F.M. Wolber (1991) A simple method for the purification of human peripheral blood monocytes - A substitute for Sepracell-MN. Journal of Immunological Methods, 144, 247-251.
32. R. Ross (1971) The smooth muscle cell, II: growth of smooth muscle cells in culture and formation of elastic fibers. Journal of Cell Biology, 50, 172-177.
33. T.F. Slater and B.C. Sawyer (1971) The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reaction in rat liver fractions in vitro. Biochemical Journal, 123, 805-808.
34. K.L.H. Carpenter, J.A. Ballantine, B. Fussell, J.H. Enright and M.J. Mitchinson (1990) Oxidation of cholesteryl linoleate by human monocyte-macrophages in vitro. Atherosclerosis, 83, 217-229.
35. C. Labarca and K. Paigen (1980) A simple, rapid, and sensitive DNA assay. Analytical Biochemistry, 102, 344-352.
36. 3H-adenine and lactate dehydrogenase. Journal of Laboratory and Clinical Medicine, 106, 253-261.
37. C. Rice-Evans, D. Leake, K.R. Bruckdorfer and A.T. Diplock (1996) Practical approaches to low density lipoprotein oxidation: whys, wherefores and pitfalls. Free Radical Research, 25, 285-311.
38. U.P. Steinbrecher, S. Parthasarathy, D.S. Leake, J.L. Witztum and D. Steinberg (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proceedings of the National Academy of Sciences of the USA, 81, 3883-3887.
39. U.P. Steinbrecher (1987) Oxidation of human low density lipoprotein results in the derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. Journal of Biological Chemistry, 262, 3603-3608.
40. M.K. Cathcart, D.W. Morel and G.M. Chisolm (1985) Monocytes and neutrophils oxidise low density lipoprotein making it cytotoxic. Journal of Leukocyte Biology, 38, 341-350.
41. V.C. Reid and M.J. Mitchinson (1993) Toxicity of oxidised low-density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis, 98, 17-24.
42. H. Esterbauer, G. Jürgens, O. Quehenberger and E. Koller (1987) Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. Journal of Lipid Research, 28, 495-509.
43. J.I. Teng and L.L. Smith (1973) Sterol metabolism. XXIV. On the unlikely participation of singlet molecular oxygen in several enzyme oxygenations. Journal of the American Chemical Society, 95, 4060-4061.
44. E. Lund, U. Diczfalusy and I. Björkhem (1992) On the mechanism of oxidation of cholesterol at C-7 in a lipoxygenase system. Journal of Biological Chemistry, 276, 12462-12467.
45. K.L.H. Carpenter, S.E. Taylor, C. Van der Veen, B.K. Williamson, J.A. Ballantine and M.J. Mitchinson (1995) Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochimica et Biophysica Acta, 1256, 141-150.
46. S. Andersson, D.L. Davis, H. Dahlback, H. Jornvall and D.W. Russell (1989) Cloning, structure, and expression of the mitochondrial cytochrome P450 sterol 26-hydroxylase, a bile-acid biosynthetic enzyme. Journal of Biological Chemistry, 264, 8222-8229.
47. N.B. Javitt (1990) 26-Hydroxycholesterol - Synthesis, metabolism, and biological activities. Journal of Lipid Research, 31, 1527-1533.
48. H. Esterbauer, J. Gebicki, H. Puhl and G. Jürgens (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biology & Medicine, 13, 341-390.
49. C. Van der Veen, K.L.H. Carpenter, S.E. Taylor, J.A. McDonald and M.J. Mitchinson (1997) Factors affecting events during oxidation of low density lipoprotein: Correlation of multiple parameters of oxidation. Free Radical Research, 27, 459-476.
50. I. Pico, I. Myara, M.-A. Pech-Ansellem, B. Vedie, B. Chappey and N. Moatti (1996) Oxidative modification of low-density lipoprotein by the human hepatoma cell line HepG2. Free Radical Research, 25, 321-336.
51. K. Müller, S.J. Hardwick, C.E. Marchant, N.S. Law, G. Waeg, H. Esterbauer, K.L.H. Carpenter and M.J. Mitchinson (1996) Cytotoxic and chemotactic potencies of several aldehydic components of oxidised low density lipoprotein for human monocyte-macrophages. FEBS Letters, 388, 165-168.
52. K. Clare, S.J. Hardwick, K.L.H. Carpenter, N. Weeratunge and M.J. Mitchinson (1995) Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis, 118, 169-172.
53. G.M. Chisolm, G. Ma, K.C. Irwin, L.L. Martin, K.G. Gunderson, L.F. Linberg, D.W. Morel and P.E. DiCorleto (1994) 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proceedings of the National Academy of Sciences of the USA, 91, 11452-11456.
54. N.M. Aqel, R.Y. Ball, H. Waldmann and M.J. Mitchinson (1985) Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. Journal of Pathology, 146, 197-204.
55. L. Jonasson, J. Holm, O. Skalli, G. Bondjers and G.K. Hansson (1986) Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis, 6, 131-138.
56. Ylä-Herttuala, M.E. Rosenfeld, S. Parthasarathy, E. Sigal, T. Särkioja, J.L. Witztum and D. Steinberg (1991) Gene expression in macrophage-rich human atherosclerotic lesions. 15-Lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. Journal of Clinical Investigation, 67, 1146-1152.
57. D.J. Benford and S.A. Hubbard (1987) Preparation and culture of mammalian cells. In Biochemical Toxicology: A Practical Approach (eds. DK. Snell and B. Mullock), IRL Press Ltd., Oxford, pp. 57-82.